Home / Tess Bryan (page 5)

Tess Bryan

Tess Bryan is an influential Health & Travel blogger helping businesses worldwide to connect with their ideal audience and sharing great citizen journalism. Connect with her via Linkedin to share your story.

Jardiance (empagliflozin)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) July 2016 WARNINGS AND PRECAUTIONS Ketoacidosis (addition of the following sentence) Fatal cases of ketoacidosis have been…

Read More »

Flovent Diskus (fluticasone propionate inhalation powder)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) July 2016 ADVERSE REACTIONS Postmarketing Experience Infections and Infestations: Esophageal candidiasis.  

Read More »

Amikacin Sulfate Injection USP 500 mg/2 mL (250 mg/mL) and 1 Gram/4 mL (250 mg/mL) Vials by Teva: Recall – Glass Particulate Matter

Audience: Pharmacy, Nursing ISSUE: Teva Pharmaceuticals announced a voluntary recall of seven lots of Amikacin Sulfate Injection USP, 500 mg/2mL (250 mg/mL) and 1 gram/4mL (250 mg/mL) vials due to the potential for the presence of glass particulate…

Read More »

Cetylev (acetylcysteine) Effervescent Tablets for Oral Solution: Recall – Inadequate Seal of Blister Pack

Audience: Pharmacy, Nursing, Emergency Medicine ISSUE: Arbor  Pharmaceuticals, LLC announced a voluntary recall of three (3) lots of Cetylev (acetylcysteine) effervescent tablets for oral solution, 500 mg, due to an inadequate seal of the…

Read More »

Eyesaline Eyewash by Honeywell: Recall – Microbial Contamination

Audience: Risk Manager, Emergency Medicine, Pharmacy ISSUE: Honeywell is voluntarily recalling one production lot of 32-ounce bottles of Eyesaline Eyewash solution, which is used for emergency eye rinsing after an injury. Although no injuries have… Powered by WPeMatico

Read More »

DHZC-2 Tablet by Ton Shen Health: Recall – Possible Health Risk

Audience: Consumer ISSUE: Ton Shen Health of Chicago, IL, is recalling its “DHZC-2” Tablets because they have the potential to be contaminated with elevated levels of lead, a naturally occurring element which can affect multiple body system and…

Read More »

Opioid Pain or Cough Medicines Combined With Benzodiazepines: Drug Safety Communication – FDA Requiring New Boxed Warnings About Serious Risks and Death

Audience: Pharmacy, Internal Medicine, Psychiatry, Neurology, Family Practice ISSUE: FDA review has found that the growing combined use of opioid medicines with benzodiazepines or other drugs that depress the central nervous system (CNS) has…

Read More »